In this video interview, Dr. Hooman Noorchashm, surgeon and patient safety advocate, explains why he’s written a second letter to the FDA urging the agency to require pre-screening for SARS-CoV-2 viral proteins in order to reduce COVID vaccine injuries and deaths.